Chilly Mazarin, France

Benoît Marabout


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Benoît Marabout: Innovator in Neuropharmacology

Introduction

Benoît Marabout is a notable inventor based in Chilly Mazarin, France. He has made significant contributions to the field of neuropharmacology, particularly through his innovative research and development of new therapeutic compounds. With a total of 2 patents to his name, Marabout's work focuses on addressing critical health issues related to peripheral neuropathies and neurodegenerative diseases.

Latest Patents

Marabout's latest patents include the development of 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives. These compounds have shown promise in their affinity for peripheral benzodiazepine receptors, which are crucial for the prevention and treatment of peripheral neuropathies. Additionally, he has patented the use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines aimed at treating diseases linked to the dysfunction of peripheral-type benzodiazepine receptors.

Career Highlights

Benoît Marabout is currently associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to collaborate with other experts in the field, enhancing the impact of his research on therapeutic applications.

Collaborations

Some of his notable coworkers include Frank Marguet and Jacques Froissant. Their collaborative efforts have contributed to advancing the understanding and treatment of various neurological conditions.

Conclusion

Benoît Marabout's innovative work in neuropharmacology exemplifies the importance of research in developing new treatments for complex health issues. His patents reflect a commitment to improving patient outcomes through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…